260 related articles for article (PubMed ID: 24944235)
1. Hepatic decompensation in patients with HIV/Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) triple infection versus HIV/HCV coinfection and the effect of anti-HBV nucleos(t)ide therapy.
Lo Re V; Wang L; Devine S; Baser O; Olufade T
Clin Infect Dis; 2014 Oct; 59(7):1027-31. PubMed ID: 24944235
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.
Fernández-Montero JV; Vispo E; Barreiro P; Sierra-Enguita R; de Mendoza C; Labarga P; Soriano V
Clin Infect Dis; 2014 Jun; 58(11):1549-53. PubMed ID: 24633686
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral therapy reduces the rate of hepatic decompensation among HIV- and hepatitis C virus-coinfected veterans.
Anderson JP; Tchetgen Tchetgen EJ; Lo Re V; Tate JP; Williams PL; Seage GR; Horsburgh CR; Lim JK; Goetz MB; Rimland D; Rodriguez-Barradas MC; Butt AA; Klein MB; Justice AC
Clin Infect Dis; 2014 Mar; 58(5):719-27. PubMed ID: 24285848
[TBL] [Abstract][Full Text] [Related]
4. Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection.
Lo Re V; Zeldow B; Kallan MJ; Tate JP; Carbonari DM; Hennessy S; Kostman JR; Lim JK; Goetz MB; Gross R; Justice AC; Roy JA
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1172-1181. PubMed ID: 28722244
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.
Chu CJ; Lee SD
J Gastroenterol Hepatol; 2008 Apr; 23(4):512-20. PubMed ID: 18397482
[TBL] [Abstract][Full Text] [Related]
6. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
Kruse RL; Kramer JR; Tyson GL; Duan Z; Chen L; El-Serag HB; Kanwal F
Hepatology; 2014 Dec; 60(6):1871-8. PubMed ID: 25065513
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.
Nelson M; Amaya G; Clumeck N; Arns da Cunha C; Jayaweera D; Junod P; Li T; Tebas P; Stevens M; Buelens A; Vanveggel S; Boven K;
J Antimicrob Chemother; 2012 Aug; 67(8):2020-8. PubMed ID: 22532465
[TBL] [Abstract][Full Text] [Related]
9. Viral hepatitis and HIV coinfection.
Sulkowski MS
J Hepatol; 2008 Feb; 48(2):353-67. PubMed ID: 18155314
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study.
Jia J; Zhu Q; Deng L; Lan G; Johnson A; Chen H; Shen Z; Li J; Xing H; Ruan Y; Li J; Lu H; Vermund SH; Zhu J; Qian HZ
Infect Dis Poverty; 2022 Jan; 11(1):7. PubMed ID: 34986877
[TBL] [Abstract][Full Text] [Related]
11. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.
Klein MB; Althoff KN; Jing Y; Lau B; Kitahata M; Lo Re V; Kirk GD; Hull M; Kim HN; Sebastiani G; Moodie EE; Silverberg MJ; Sterling TR; Thorne JE; Cescon A; Napravnik S; Eron J; Gill MJ; Justice A; Peters MG; Goedert JJ; Mayor A; Thio CL; Cachay ER; Moore R; ;
Clin Infect Dis; 2016 Nov; 63(9):1160-1167. PubMed ID: 27506682
[TBL] [Abstract][Full Text] [Related]
12. Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group.
Crespo M; Navarro J; Moreno S; Sanz J; Márquez M; Zamora J; Ocampo A; Iribaren JA; Rivero A; Llibre JM
Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):493-498. PubMed ID: 27061975
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
da Silva CM; de Peder LD; Guelere AM; Horvath JD; Silva ES; Teixeira JJV; Bertolini DA
PLoS One; 2018; 13(9):e0203272. PubMed ID: 30192795
[TBL] [Abstract][Full Text] [Related]
14. Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study.
Lo Re V; Kallan MJ; Tate JP; Localio AR; Lim JK; Goetz MB; Klein MB; Rimland D; Rodriguez-Barradas MC; Butt AA; Gibert CL; Brown ST; Park L; Dubrow R; Reddy KR; Kostman JR; Strom BL; Justice AC
Ann Intern Med; 2014 Mar; 160(6):369-79. PubMed ID: 24723077
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of raltegravir in patients with HIV-1 and hepatitis B and/or C virus coinfection.
Rockstroh J; Teppler H; Zhao J; Sklar P; Harvey C; Strohmaier K; Leavitt R; Nguyen BY
HIV Med; 2012 Feb; 13(2):127-31. PubMed ID: 21599819
[TBL] [Abstract][Full Text] [Related]
16. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
Yu ML; Lee CM; Chen CL; Chuang WL; Lu SN; Liu CH; Wu SS; Liao LY; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Su WW; Lin CL; Yang HC; Chen PJ; Chen DS; Liu CJ;
Hepatology; 2013 Jun; 57(6):2135-42. PubMed ID: 23322699
[TBL] [Abstract][Full Text] [Related]
17. The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis.
Liu JY; Sheng YJ; Hu HD; Zhong Q; Wang J; Tong SW; Zhou Z; Zhang DZ; Hu P; Ren H
Virol J; 2012 Sep; 9():186. PubMed ID: 22950520
[TBL] [Abstract][Full Text] [Related]
18. Liver Fibrosis Progression and Mortality in Hepatitis B- and C-Coinfected Persons Treated With Directly Acting Antiviral Agents: Results From ERCHIVES.
Butt AA; Yan P; Aslam S; Abou-Samra AB; Sherman KE; Shaikh OS
Clin Infect Dis; 2020 Jul; 71(3):664-666. PubMed ID: 31840746
[TBL] [Abstract][Full Text] [Related]
19. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
Merchante N; Rivero-Juárez A; Téllez F; Merino D; José Ríos-Villegas M; Márquez-Solero M; Omar M; Macías J; Camacho A; Pérez-Pérez M; Gómez-Mateos J; Rivero A; Antonio Pineda J;
Hepatology; 2012 Jul; 56(1):228-38. PubMed ID: 22278746
[TBL] [Abstract][Full Text] [Related]
20. Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature.
Fabbri G; Mastrorosa I; Vergori A; Mazzotta V; Pinnetti C; Grisetti S; Zaccarelli M; Ammassari A; Antinori A
BMC Infect Dis; 2017 Mar; 17(1):182. PubMed ID: 28249574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
